ACR Share Price

Open 0.28 Change Price %
High 0.30 1 Day 0.00 0.00
Low 0.28 1 Week -0.02 -6.67
Close 0.28 1 Month -0.04 -12.50
Volume 3184196 1 Year -0.39 -58.21
52 Week High 0.83
52 Week Low 0.28
ACR Important Levels
Resistance 2 0.30
Resistance 1 0.29
Pivot 0.29
Support 1 0.27
Support 2 0.26
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
GPP 0.04 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
SDL 0.01 0.00%
SDL 0.01 0.00%
SDL 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
SER 0.02 100.00%
SER 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
ARV 0.12 33.33%
PRR 0.04 33.33%
PRR 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RMI 0.01 -50.00%
RMI 0.01 -50.00%
IMU 0.01 -50.00%
IMU 0.01 -50.00%
GDY 0.01 -50.00%
More..

Acrux Ltd (ASX: ACR)

ACR Technical Analysis 5
As on 24th Feb 2017 ACR Share Price closed @ 0.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.49 & Strong Sell for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
ACR Target for February
1st Target up-side 0.33
2nd Target up-side 0.34
3rd Target up-side 0.35
1st Target down-side 0.29
2nd Target down-side 0.28
3rd Target down-side 0.27
ACR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.acrux.com.au
ACR Address
ACR
103-113 Stanley Street
West Melbourne, VIC 3003
Australia
Phone: 61 3 8379 0100
Fax: 61 3 8379 0101
ACR Latest News
Interactive Technical Analysis Chart Acrux Ltd ( ACR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Acrux Ltd
ACR Business Profile
Acrux Limited, a drug delivery company, develops and commercializes a range of patient-preferred and patented pharmaceutical products using its technology to administer proven medicines through the skin. The company’s products include Axiron to treat testosterone deficiency in men; Evamist for menopause symptoms; and Recuvyra pain relief for dogs. Its product under registration comprises Estradiol MDTS for menopause symptoms. The company is also developing Luramist for female HSDD; Nestorone MDTS for contraception; Nicotine MDTS for smoking cessation; and NSAIDs for pain and inflammation. It operates in Australia, accessing international pharmaceutical markets through commercial partners. Acrux was founded in 1998 and is based in West Melbourne, Australia.